Plunkett Research Online: Inotiv Inc

INOTIV INC (NOTV:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery and development services to the pharmaceutical, chemical, and medical device industries. It operates in two principal segments; Discovery and Safety Assessment (DSA) and Research Models and S.....



Inotiv Inc
Ticker: NOTV
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 765 463-4527
Fax: 765 497-1102
Address: 2701 Kent Avenue
West Lafayette, IN 47906 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contract Research Services
Contract Research
Non-Clinical Drug Discovery
Non-Clinical Drug Development Services
Scientific Instruments
Software
1. Siemens USA17,791,100,000
2. IQVIA Holdings Inc14,410,000,000
3. ICON plc7,741,386,000
4. Syneos Health Inc5,393,082,000
5. PPD Inc4,681,474,000
6. Charles River Laboratories International Inc3,976,060,000
7. PRA Health Sciences Inc3,183,365,000
8. PAREXEL International Corporation2,665,000,000
9. Medpace Holdings Inc1,459,996,000
10. BGI Genomics Co Ltd1,286,500,000
12. Inotiv Inc547,656,000
Contacts Description
Robert LeasureCEO/Director/President
Beth TaylorCFO/Senior VP, Divisional
Gregory DavisChairman of the Board/Director
Brennan FreemanChief Accounting Officer/Controller/Vice President, Divisional
John SagartzChief Strategy Officer/Director
John BeattieCOO
Nigel BrownDirector
David LandmanDirector
Richard JohnsonDirector
R. NeffDirector
Fernanda BeraldiGeneral Counsel/Secretary
William PitchfordOther Executive Officer
Michael GarrettOther Executive Officer
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery and development services to the pharmaceutical, chemical, and medical device industries. It operates in two principal segments; Discovery and Safety Assessment (DSA) and Research Models and S.....
See More

Auditor: RSM US LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202220212020201920182017
Financials
    Revenue547,656,00089,605,00060,469,00043,616,00026,346,00024,242,000
    Cost of Revenue390,444,00059,449,00042,232,00030,695,00018,230,00016,545,000
    Gross Margin %28.7133.6530.1629.6230.8131.75
    R&D Expense - 405,000950,000627,000596,000465,000
    Operating Income20,251,000(5,618,000)(3,063,000)(153,000)14,0001,278,000
    Operating Margin %3.70-6.27-5.07-0.350.055.27
    SGA Expense99,086,00033,892,00020,350,00012,447,0007,506,0005,954,000
    Net Income(337,018,000)10,895,000(4,685,000)(790,000)(194,000)884,000
    Earnings Per Share-13.840.83-0.43-0.08-0.020.11
    Dividends - - - - - -
    Book Value Per Share - - - - - -
    Operating Cash Flow(5,217,000)10,746,0001,290,0001,777,0003,487,0001,236,000
    Capital Expenditure36,300,00012,472,0006,200,0006,878,0001,317,000347,000
    Free Cash Flow(41,517,000)(1,726,000)(4,910,000)(5,101,000)2,170,000889,000
Profitability
    EBITDA(273,421,000)14,070,000881,0002,573,0001,895,0002,963,000
    Return on Assets %-52.465.68-9.05-2.16-0.754.25
    Return on Equity %-144.8019.33-51.35-7.34-2.1212.90
    Net Margin %-61.5412.16-7.75-1.81-0.743.65
    Assets Turnover0.850.471.171.191.021.17
    Financial Leverage2.673.068.143.932.882.75
Brands, Divisions and Affiliates Top Salaries
Bioanalytical Systems Inc
NameTitleSalary (US$)Bonus (US$)
Robert LeasureCEO/President450,751100,000
John SagartzChief Strategy Officer322,67456,000
Beth TaylorCFO273,63556,000
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: